{"id":"W2318415095","doi":"10.1186/s40064-016-2008-9","title":"Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice","year":2016,"lang":"en","type":"article","venue":"SpringerPlus","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"U.S. Navy; Genentech; U.S. Department of Defense","keywords":"Trastuzumab; Medicine; Adjuvant; Breast cancer; Clinical Practice; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306632,0.0001281804,0.0002932965,0.0004355309,0.0002155674,0.0004614704,0.0002343581,0.0003712975,0.001121419],"category_scores_gemma":[0.003528034,0.0001171625,0.0002529684,0.001015184,0.0001950955,0.0003520618,0.0003362767,0.0003695968,0.000156778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005182968,"about_ca_system_score_gemma":0.000444071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002544955,"about_ca_topic_score_gemma":0.003421735,"domain_scores_codex":[0.9995467,0.0001373104,0.00005801373,0.0001210351,0.00008202934,0.00005487509],"domain_scores_gemma":[0.9984023,0.0002675315,0.0009903185,0.00004207543,0.0001043134,0.0001935076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001909441,0.00004239074,0.995618,0.00002633153,0.00004932465,0.00007489331,0.00004492654,0.00007727517,0.00007100683,0.00002364587,0.0002285591,0.003552664],"study_design_scores_gemma":[0.00006069458,0.0002263858,0.9979809,0.00003004809,0.00005317642,0.0005312978,0.0001038112,0.0003472282,0.00006828613,0.0001202376,0.0004737827,0.000004211472],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971007,0.00151243,0.00005828985,0.000304459,0.000008439389,0.00001192976,0.0003837196,0.000004125404,0.0006158779],"genre_scores_gemma":[0.9989952,0.0004380618,0.00005166236,0.00007312276,0.00001506584,0.000008180505,0.0003477267,6.613724e-7,0.00007018646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002544955,"threshold_uncertainty_score":0.005060256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02936261070029393,"score_gpt":0.3779138114276678,"score_spread":0.3485512007273739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}